EP3555064
GLP-1 viðtakagerandefni og notkun þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.12.2017EP published:
23.11.2022EP application number:
17817174.0
EP translation filed:
19.12.2022Grant published:
15.1.2023EPO information:
European Patent Register
Max expiry date:
30.11.2037Expiry date:
30.11.2025Next due date:
30.12.2025
Title in English:
GLP-1 RECEPTOR AGONISTS AND USES THEREOFLanguage of the patent:
English
Timeline
Today
1.12.2017EP application
23.11.2022EP Publication
19.12.2022Translation submitted
15.1.2023Registration published
30.11.2025Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
ASPNES, Gary ErikAddress:
Hopkinton, MA 01748, US
Name:
BAGLEY, Scott W.Address:
Mystic, CT 06355, US
Name:
CURTO, John M.Address:
Mystic, CT06355, US
Name:
DOWLING, Matthew S.Address:
Old Lyme, CT 06371, US
Name:
EDMONDS, David JamesAddress:
Arlington, MA 02474, US
Name:
FLANAGAN, Mark E.Address:
Gales Ferry, CT 06335, US
Name:
FUTATSUGI, KentaroAddress:
Quincy, MA 02169, US
Name:
GRIFFITH, David A.Address:
Sudbury, MA 01776, US
Name:
HUARD, KimAddress:
Medford, MA 02155, US
Name:
INGLE, GajendraAddress:
Groton, CT 06340, US
Name:
JIAO, WenhuaAddress:
Salem, CT 06420, US
Name:
LIMBERAKIS, ChrisAddress:
Pawcatuck, CT 06379, US
Name:
MATHIOWETZ, Alan M.Address:
Quaker Hill, CT 06375, US
Name:
PIOTROWSKI, David W.Address:
Waterford, CT 06385, US
Name:
RUGGERI, Roger B.Address:
Waterford, CT 06385, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662435533 PDate:
16.12.2016Country:
US
Classification
Categories:
C07D 401/14, C07D 405/14, C07D 413/14, C07D 471/04, C07D 487/04, A61K 31/497, A61K 31/4427, A61P 3/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 23.1.2023
Expires: 30.11.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 15.11.2023
Expires: 30.11.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.11.2024
Expires: 30.11.2025
Payer: Árnason Faktor ehf.